Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tai-Tsang Chen

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Journal of the National Cancer Institute|June 27, 2015
Milestone Survival: A Potential Intermediate Endpoint for Immune Checkpoint InhibitorsTai-Tsang Chen
BMC Medical Research Methodology|February 3, 2016
Predicting analysis times in randomized clinical trials with cancer immunotherapyTai-Tsang Chen
Cancer Immunology Research|July 26, 2019
Designing Late-Stage Randomized Clinical Trials with Cancer Immunotherapy: Can We Make It Simpler?Tai-Tsang Chen
Journal for Immunotherapy of Cancer|May 16, 2014
Statistical issues and challenges in immuno-oncologyTai-Tsang Chen
Cancer Immunology Research|December 9, 2015
Statistical Challenges in the Design of Late-Stage Cancer Immunotherapy StudiesRosemarie Mick, Tai-Tsang Chen
Clinical Trials (London, England)|November 11, 2005
Nonparametric prediction of event times in randomized clinical trialsGui-shuang Ying, Daniel F Heitjan, Tai-Tsang Chen
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 7, 2013
Exposure-response relationships of the efficacy and safety of ipilimumab in patients with advanced melanomaYan Feng, Amit Roy, Eric Masson, et al.
Clinical Pharmacology : Advances and Applications|June 22, 2013
Differential effects of dosing regimen on the safety and efficacy of dasatinib: retrospective exposure-response analysis of a Phase III studyXiaoning Wang, Amit Roy, Andreas Hochhaus, et al.
Statistics in Medicine|February 14, 2025
Using Win Odds to Improve Commit-to-Phase-3 Decision-Making in OncologyBenjamin F Hartley, Thomas Drury, Brian Di Pace, et al.
Frontiers in Oncology|November 30, 2023
Basket trials in oncology: a systematic review of practices and methods, comparative analysis of innovative methods, and an appraisal of a missed opportunityAdetayo Kasim, Nathan Bean, Sarah Jo Hendriksen, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Journal of the National Cancer Institute|June 27, 2015
Milestone Survival: A Potential Intermediate Endpoint for Immune Checkpoint InhibitorsTai-Tsang Chen
BMC Medical Research Methodology|February 3, 2016
Predicting analysis times in randomized clinical trials with cancer immunotherapyTai-Tsang Chen
Cancer Immunology Research|July 26, 2019
Designing Late-Stage Randomized Clinical Trials with Cancer Immunotherapy: Can We Make It Simpler?Tai-Tsang Chen
Journal for Immunotherapy of Cancer|May 16, 2014
Statistical issues and challenges in immuno-oncologyTai-Tsang Chen
Cancer Immunology Research|December 9, 2015
Statistical Challenges in the Design of Late-Stage Cancer Immunotherapy StudiesRosemarie Mick, Tai-Tsang Chen
Clinical Trials (London, England)|November 11, 2005
Nonparametric prediction of event times in randomized clinical trialsGui-shuang Ying, Daniel F Heitjan, Tai-Tsang Chen
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 7, 2013
Exposure-response relationships of the efficacy and safety of ipilimumab in patients with advanced melanomaYan Feng, Amit Roy, Eric Masson, et al.
Clinical Pharmacology : Advances and Applications|June 22, 2013
Differential effects of dosing regimen on the safety and efficacy of dasatinib: retrospective exposure-response analysis of a Phase III studyXiaoning Wang, Amit Roy, Andreas Hochhaus, et al.
Statistics in Medicine|February 14, 2025
Using Win Odds to Improve Commit-to-Phase-3 Decision-Making in OncologyBenjamin F Hartley, Thomas Drury, Brian Di Pace, et al.
Frontiers in Oncology|November 30, 2023
Basket trials in oncology: a systematic review of practices and methods, comparative analysis of innovative methods, and an appraisal of a missed opportunityAdetayo Kasim, Nathan Bean, Sarah Jo Hendriksen, et al.
Pageof 3